Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on Medivir’s new issue
Mandate

Vinge advises on Medivir’s new issue

March 29, 2010

Medivir AB (publ) (NASDAQ OMX Stockholm) is performing a rights issue for approximately SEK 300 million. The new issue is fully covered by subscription undertakings, declarations of intent and underwriting undertakings from, among others, Carnegie and Jefferies acting as Joint Bookrunners.

Vinge is advising Medivir. Vinge’s team consists of Erik Sjöman, Emil Hedberg and Jesper Schönbeck. In addition, Rikard Stenberg, Maria Doeser and Markus Larsson have been involved in the transaction.

Related

Naval Group signs contract for four defence and intervention frigates (FDI) for the Royal Swedish Navy

 Vinge has advised Naval Group in connection with the negotiations with the Swedish Defence Materiel Administration (FMV) for the procurement of four defence and intervention frigates (FDI) for the Swedish Navy. The contract was signed on 31 August 2026 in Stockholm. Naval Group has been selected as a strategic partner by the Swedish Government to rapidly strengthen and modernise its fleet's capabilities.
September 08, 2026

Vinge advises Axcel and Sanviva on the acquisitions of DermaCura and YourRad

 Vinge has advised Axcel Elevate I and Sanviva in connection with the acquisitions of DermaCura and YourRad.
September 07, 2026

Vinge advises Revivo Group on the acquisition of Premator

 Revivo Group AB has acquired all the shares in Premator AB, the parent company of a group operating in the field of advanced surface treatment with extensive experience in shot blasting, anti-corrosion painting and related services. Operations are conducted in Sweden, Norway and Denmark.
September 03, 2026